IC
HAE icon

IEQ Capital’s Haemonetics HAE Stock Holding History

IEQ Capital’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.18M Sell
20,998
-9,326
-31% -$607K 0.01% 968
2025
Q4 		$2.43M Buy
30,324
+25,887
+583% +$1.74M 0.01% 729
2025
Q3 		$216K Buy
+4,437
New +$275K ﹤0.01% 1654

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

IEQ Capital's HAE Position: Q1 2026 in Review

IEQ Capital reduced its Haemonetics (HAE) stake by 31% in Q1 2026, selling an estimated $607K and leaving 20,998 shares worth $1.18M. The position accounts for 0.01% of the portfolio, ranked #968.

IEQ Capital first reported a position in HAE in Q3 2025 and has held it in 3 quarters since. The position peaked at $2.43M in Q4 2025. 324 funds tracked by Wall St. Rank hold HAE as of Q1 2026.

  • IEQ Capital held 20,998 shares of Haemonetics worth $1.18M as of Q1 2026.
  • IEQ Capital sold 9,326 Haemonetics shares in Q1 2026, an estimated $607K.
  • Haemonetics made up 0.01% of IEQ Capital's portfolio in Q1 2026, its #968 holding.
  • IEQ Capital first reported a position in Haemonetics in Q3 2025 and has held it in 3 quarters since.
  • IEQ Capital's Haemonetics position peaked at $2.43M in Q4 2025.
  • 324 funds tracked by Wall St. Rank held Haemonetics as of Q1 2026.

Based on IEQ Capital's 13F filing for Q1 2026, filed 15 May 2026.